Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion type Assertion NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_head.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion description "[Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_provenance.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion evidence source_evidence_literature NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_provenance.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion SIO_000772 15695058 NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_provenance.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion wasDerivedFrom gad-20150221 NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_provenance.
- NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_assertion wasGeneratedBy ECO_0000203 NP73079.RAuKzihFpfXutbs2Pgif1m9RuRtQEgbqF9-zfwuoWsR7Q130_provenance.